American Herbal Products Association (AHPA) > News > AHPA in the News

AHPA in the News

Supplement Industry Associations Applaud FDA Actions to Protect Consumers from Fraudulent Products Related to Coronavirus Disease (COVID-19)

Washington D.C., April 6, 2020

The U.S. dietary supplement industry commends the Food and Drug Administration (FDA) for taking action to protect consumers by calling out marketers who make illegal and unsubstantiated drug claims related to COVID-19, the disease caused by the novel coronavirus, SARS-CoV-2. In February, the industry issued strong warning to companies and consumers to avoid marketing or using dietary supplements that are presented as treating, curing or preventing COVID-19.

March 2020 AHPA in the News


DHS-CISA updates their guidance, cites "dietary supplement" workers as essential critical infrastructure workers

Revised guidance provides numerous and significant additional details in identifying essential critical infrastructure workers and sectors

Revised guidance provides numerous and significant additional details in identifying essential critical infrastructure workers and sectors in several categories, including, among others, healthcare, law enforcement, transportation, and food and agriculture.

Dietary supplement, other herbal product, and cannabis operations identified as “essential businesses” and “critical infrastructure”

Designation implied by numerous regulatory agencies; explicit in California

Federal, state, and local governments’ actions to address the novel coronavirus and COVID-19 have consistently included recommendations promoting or directives requiring social distancing as a key protective measure to minimize community spread of this disease. In making stay-at-home recommendations or issuing shelter-in-place orders, health agencies and other official bodies have identified certain industries as “essential businesses” or “critical infrastructure” whose employees and operations are (or should be) exempt from these recommendations and directives.

FDA to limit domestic inspections to “mission critical” cases; pre-announce the majority of such inspections; waive certain FSMA onsite audit requirements

Much of the teleconference was focused on the Agency’s online resources, such as its FAQ page, which was recently updated

The U.S. Food and Drug Administration (FDA) convened a teleconference meeting on March 18 (FDA Briefing for Foods Stakeholders on Coronavirus Disease 2019 (COVID-19)), which was attended by AHPA president Michael McGuffin and by representatives of AHPA’s general counsel, Kleinfeld, Kaplan & Becker, LLP.

AHPA joins leading health and food organizations to urge lawmakers to clearly define exemptions to shelter-in-place orders

Three letters urge clear definition of employee exemptions for shelter-in-place orders

In a series of three letters to federal, state, and local governments, AHPA joined healthcare and food organizations to request that uniform language be included in shelter-at-home orders that provide direction to employees working in various industries related to dietary supplements, healthcare, and pharmaceuticals.

AHPA Hemp-CBD Supplement Congress

AHPA Hemp-CBD Supplement Congress

Aug. 26-27, 2020 -- Venue and online platform TBD

Due to overwhelming demand, AHPA is presenting a second, expanded Hemp-CBD Supplement Congress to provide companies with an understanding of federal and state legal and regulatory obligations and current issues and opportunities in the hemp-CBD market. Location and online platform have yet to be determined

AHPA COVID-19 Information & Resources Web Center

Answers to FAQs regarding COVID-19 impact on dietary supplements and food

AHPA has compiled answers to frequently asked questions and resources to help prepare for and respond to COVID-19. This page will be revised and updated regularly as new information about the novel coronavirus (SARS-CoV-2) and possible impacts on the herbal products industry and the people who work in this trade becomes available.

AHPA Cannabis Committee Celebrates a Decade of Industry Leadership

AHPA Cannabis Committee Celebrates a Decade of Industry Leadership

For 10 years AHPA’s Cannabis Committee has been actively involved in the regulatory, legislative, and technical aspects of moving cannabis (including hemp-CBD) into the legal marketplace

Silver Spring, MD – The American Herbal Products Association (AHPA), the voice of the herbal products industry, celebrates the 10-year anniversary of its Cannabis Committee today. The Committee was established on March 10, 2010 to address issues related to the safe use and responsible commerce of legally-marketed products derived from Cannabis species, including hemp and hemp-derived cannabidiol (CBD).
Adverse Event Reporting Tells the Story of Dietary Supplement Safety

Adverse Event Reporting Tells the Story of Dietary Supplement Safety

FDA AER data often lacks fields that may prevent misinterpretation, including FDA’s assessment of causation

Washington, D.C. — At the initial Congressional Dietary Supplement Caucus briefing of 2020, held last week, Dr. Richard Kingston, president, regulatory and scientific affairs and co-founder of SafetyCall International, educated congressional staffers on the types of evidence used to monitor dietary supplement safety, including adverse event reports, emergency room visits and poison control center data. Dr. Kingston is an expert on clinical toxicology and pharmacology, poison control, product post-market surveillance, and drug and dietary supplement safety.
RSS
123456789

2020 Annual Fund Sponsors

   

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.